Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

Novo Nordisk terminates collaboration with Hims & Hers Health, Inc. due to concerns about their illegal mass compounding and ...

We came across a bullish thesis on Verve Therapeutics, Inc. on Stock Region Research’s Substack by Stock Region. In this ...

Learn about June 2025’s top biotech deals, featuring major collaborations in small molecules, protein therapeutics, and ...

Emerging oligonucleotides and gene editing therapies offer greater precision, long-term efficacy, and improved adherence in comparison to traditional statin therapies. This is especially true for ...

AbbVie has agreed to buy Capstan Therapeutics for up to $2.1 billion, expanding its pipeline with a potential first-in-class ...

Big Pharmas like Eli Lilly, Sanofi and Novartis headed back to the dealmakers table multiple times, with 32 total deals ...

BMO Capital Markets cut shares of Verve Therapeutics (NASDAQ:VERV – Free Report) from a strong-buy rating to a hold rating in a report published on Thursday,Zacks.com reports. VERV has been the ...

Verve Therapeutics (NASDAQ:VERV – Get Free Report)‘s stock had its “market perform” rating reaffirmed by equities researchers at BMO Capital Markets in a research report issued on Friday ...

Fintel reports that on June 27, 2025, BMO Capital downgraded their outlook for Verve Therapeutics (NasdaqGS:VERV) from Outperform to Market Perform. Analyst Price Forecast Suggests 27.12% Upside As of ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.